Brain-targeted delivery of siRNA via non-viral delivery systems, the therapeutic strategy for Alzheimer's disease—Unveiling challenges and prospects
Open Access
- 5 February 2026
- journal article
- review article
- Published by Elsevier in International Journal of Pharmaceutics: X
- Vol. 11, 100503
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82405051)
This publication has 173 references indexed in Scilit:
- Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escapeNature Biotechnology, 2013
- β‐Site amyloid precursor protein–cleaving enzyme 1 activity is related to cerebrospinal fluid concentrations of sortilin‐related receptor with A‐type repeats, soluble amyloid precursor protein, and tauAlzheimer's & Dementia, 2012
- Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytesNucleic Acids Research, 2012
- Sphingolipid-modulated Exosome Secretion Promotes Clearance of Amyloid-β by MicrogliaJournal of Biological Chemistry, 2012
- Delivery of Quantum Dot-siRNA Nanoplexes in SK-N-SH Cells for BACE1 Gene Silencing and Intracellular ImagingMolecular Therapy Nucleic Acids, 2012
- Loss of Function of ATXN1 Increases Amyloid β-Protein Levels by Potentiating β-Secretase Processing of β-Amyloid Precursor ProteinJournal of Biological Chemistry, 2010
- MMP-9 gene silencing by a quantum dot–siRNA nanoplex delivery to maintain the integrity of the blood brain barrierBrain Research, 2009
- RNA interference based gene therapy for neurological diseaseBriefings in Functional Genomics and Proteomics, 2007
- RNAiCell, 2000
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993